J&J Mastered Cancer Biotech Deals on the Cheap. Can It Stay on the Cutting Edge?

Corroborated by 2 sources from 2 publishers

globalhealth3d ago

TL;DR

J&J Mastered Cancer Biotech Deals on the Cheap. Can It Stay on the Cutting Edge. Johnson & Johnson seems to have perfected the art of the biotech deal.

Sources

1

Dow Jones WSJ

https://www.wsj.com/health/pharma/j-j-mastered-cancer-biotech-deals-on-the-cheap-can-it-stay-on-the-cutting-edge-bc1bab56?mod=rss_Technology

3d ago

2

Yahoo Finance News

https://finance.yahoo.com/sectors/healthcare/articles/j-j-mastered-cancer-biotech-093000222.html

3d ago